Monitoring liver tumor therapy with [18F]FDG positron emission tomography.
Positron emission tomography (PET) with [18F]-2-flurodeoxy-glucose (FDG) can be utilized as a functional imaging modality for monitoring liver tumor therapy. We report three cases in which PET-FDG was more useful for this purpose than other imaging methods and tumor markers.
Nagata
Y
Y
Department of Radiology, Kyoto University Hospital, Japan.
Yamamoto
K
K
Hiraoka
M
M
Abe
M
M
Takahashi
M
M
Akuta
K
K
Nishimura
Y
Y
Jo
S
S
Masunaga
S
S
Kubo
S
S
D000328:Adult; D003837:Deoxy Sugars; D003847:Deoxyglucose / Q000031:analogs & derivatives; D004621:Embolization, Therapeutic; D005260:Female; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D009364:Neoplasm Recurrence, Local; D014055:Tomography, Emission-Computed; D014057:Tomography, X-Ray Computed
D003837:Deoxy Sugars; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D003847:Deoxyglucose